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Background. The accuracy of dose calculation is crucial for success of the radiotherapy treatment. One of the 
methods that represent the current standard for patient-specific dosimetry is the evaluation of dose distributions 
measured with an ionization chamber array inside a homogeneous phantom using gamma method. Nevertheless, 
this method does not replicate the realistic conditions present when a patient is undergoing therapy. Therefore, to 
more accurately evaluate the treatment planning system (TPS) capabilities, gamma passing rates were examined for 
beams of different complexity passing through inhomogeneous phantoms. 
Materials and methods. The research was performed using Siemens Oncor Expression linear accelerator, Siemens 
Somatom Open CT simulator and Elekta Monaco TPS. A 2D detector array was used to evaluate dose distribution ac-
curacy in homogeneous, semi-anthropomorphic and anthropomorphic phantoms. Validation was based on gamma 
analysis with 3%/3mm and 2%/2mm criteria, respectively.
Results. Passing rates of the complex dose distributions degrade depending on the thickness of non-water equiva-
lent material. They also depend on dose reporting mode used. It is observed that the passing rate decreases with plan 
complexity. Comparison of the data for all set-ups of semi-anthropomorphic and anthropomorphic phantoms shows 
that passing rates are higher in the anthropomorphic phantom.
Conclusions. Presented results raise a question of possible limits of dose distribution verification in assessment of plan 
delivery quality. Consequently, good results obtained using standard patient specific dosimetry methodology do not 
guarantee the accuracy of delivered dose distribution in real clinical cases.
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Introduction  
The accuracy of dose calculation and precise dose 
delivery are crucial factors in the radiotherapy 
treatment process. There is a common agreement 
that Monte Carlo (MC) simulation is the most 
promising method for accurate calculation of ab-
sorbed dose.1,2 In MC based systems the absorbed 
dose calculated to be delivered by external photon 
beams can be reported either as dose-to-media 
(Dm) or dose-to-water (Dw), and there is still no 
general agreement regarding the choice of the cal-
culation method.1-3 Hence, experimental verifica-
tion is essential to validate algorithms before clini-
cal use.4 These verifications need to be performed 
using different dosimetric techniques and phan-
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toms of different complexity (e.g. homogeneous, 
semi-anthropomorphic, anthropomorphic). The 
complexity of the phantom is especially important 
since it has been shown3,5,6 that performance of al-
gorithms in the heterogeneous medium can differ 
significantly depending on reporting mode used. 
Namely, our earlier investigation confirmed previ-
ously published results when the calculated val-
ues according to respective reporting mode were 
compared with values measured using ionization 
chambers in media of various densities. In case 
of water equivalent media, dose differences were 
less than 2%.2,3,7 Similar results were acquired in 
low-density media.1,8 However, differences in ab-
sorbed dose between two reporting modes were 
found to be as high as 10–15% when calculated in 
high-density media2,3,9 due to their inherent limita-
tions and differences. Compared to the measured 
values, the differences between Dm and Dw ap-
proaches in high-density media (e.g. bones) were 
significant and of opposite sign.2,3 This problem 
was of particular interest for our group, and ex-
tensive work was performed using a methodology 
based on absorbed dose measurements with ioni-
zation chambers. We found a plausible solution for 
this problem which can be of practical use when 
measurements for commissioning of different re-
porting modes of treatment planning system (TPS) 
algorithm are performed.  Nevertheless, due to the 
comprehensiveness of this research, the results are 
prepared to be published as separate research else-
where.
In addition to these point dose verifications, 
where ionization chamber was placed in the phan-
tom volumes of different densities, we investigated 
the performance of the system for the 2D dosimet-
ric verification of dose distributions, which is col-
loquially known as patient-specific dosimetry. It 
is well known that this type of verification should 
be performed before the first fraction of patient’s 
therapy. Patient specific 2D dosimetry can be per-
formed either using film or arrays of ionization 
chambers or diodes. One of the first 2D detectors 
was radiographic film, but it is energy dependent10 
and nowadays it is replaced by radiochromic film. 
Radiochromic film is a detector with a high spa-
tial resolution and it is almost energy independent. 
Furthermore, it is almost water equivalent, which 
makes it convenient for measurements of dose dis-
tributions produced by high energy photon beams 
used for radiotherapy.11 Nevertheless, handling 
and processing of radiochromic films using flatbed 
scanners makes its use rather complex for every-
day patient specific dosimetry. Consequently, ar-
rays of ionization chambers or diodes are devices 
of choice for routine patient dose distribution veri-
fications. One of the methods that represent the 
current standard for patient-specific dosimetry is 
the evaluation of dose distributions measured with 
an ionization chamber array inside a homogene-
ous phantom using gamma method.12,13 Because 
beams pass through homogeneous water equiva-
lent media, this does not replicate the realistic 
conditions present when a patient is undergoing 
therapy. Therefore, to evaluate the accuracy of the 
TPS calculations more in detail, gamma method-
ology was used for verification of resulting dose 
distribution produced by photon beams passing 
through inhomogeneous phantoms in different 
geometries. Calculated dose distributions were ob-
tained using Dm and Dw reporting modes. Also, to 
better differentiate the underlying reasons for pos-
sible discrepancies, a selection of several plans was 
evaluated, ranging from simple square field to in-
tensity modulated radiation therapy (IMRT) plans 
of various complexity. The results and analysis of 
this research will be presented.
Materials and methods
In this study, the research was performed using 
devices which are in clinical use at Radiotherapy 
Department of University Hospital Rijeka, Croatia: 
linear accelerator Siemens Oncor Expression (6 
MV photon beam) equipped with multileaf col-
limator with 160 leaves (leaf width 0.5 cm at iso-
centre), Somatom Open CT simulator (Siemens 
Healthineers, Erlangen, Germany) and-Monaco v. 
5.11.02 TPS (Elekta, Stockholm, Sweden). Linear 
accelerator was commissioned and prepared for 
the clinical implementation of the IMRT according 
to international standards.14-17 
A 2D detector array IBA MatriXX  (IBA Dosimetry 
GmbH, Schwarzenbruck, Germany) with 1020 ion 
chambers spaced at approximately 0.7 cm distance 
one from another was used to evaluate TPS accu-
racy in homogeneous MultiCube phantom (IBA 
Dosimetry GmbH, Schwarzenbruck, Germany) 
and inhomogeneous phantoms: CIRS Thorax 
semi-anthropomorphic phantom (Computerized 
Imaging Reference Systems Inc., Norfolk, USA) 
and Alderson Radiation Therapy (ART) anthro-
pomorphic phantom (Radiology Support Devices, 
Long Beach, USA). CIRS semi-anthropomorphic 
phantoms are well known to all involved in dosi-
metric verification of TPS performance for point 
measurements using ionization chambers.18-21 In 
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present study, the CIRS Thorax phantom, where 
volumes of three different densities (water equiv-
alent, low-density and high-density) are built-
in, was used along with a 2D detector for transit 
dosimetry. For a better resemblance to a realistic 
situation, the methodology was also verified us-
ing three parts of the Alderson phantom; head and 
neck (H&N), thorax and pelvis. 
Gamma analysis was used to quantify the dif-
ferences between measured and calculated dose 
distributions using criteria of 3 mm distance-to-
agreement (DTA) and 3% relative dose difference 
(3%/3 mm).17 To study the effects of more stringent 
criteria on the passing rate, we also used 2%/2 mm 
criteria. Gamma analysis was performed using 
commercial software OmniPro-I’mRT v. 1.7b (IBA 
Dosimetry GmbH, Schwarzenbruck, Germany). 
Therefore, measured planar dose distribution was 
taken as a reference distribution according to which 
calculated distribution is evaluated. The data were 
analysed according to following parameters- glob-
al gamma normalization, dose maximum to 100%; 
threshold: 10% of the maximum dose; search dis-
tance: 4.5 mm. 
Calculated data along with data measured using 
a 2D detector were used for the evaluation of gam-
ma analysis results considering the dependence 
on inhomogeneous media, different complexities 
of radiotherapy plans and different phantom con-
figurations. Phantoms were scanned in all measur-
ing set-ups, and the appropriate relative electron 
density tables were assigned. To increase the ex-
perimental complexity, a 2D detector was placed 
under different measuring conditions (Figure 1) 
using above mentioned phantoms. Patient specific 
dosimetry (PSD) is regularly performed by plac-
ing the detector (IBA Matrixx) in the homogeneous 
phantom MultiCube, which is shown in Figure 1A. 
This phantom is built of tissue equivalent plastic 
and 10 cm of it is placed in front of the detector, 
on the beam path. To increase the experimental 
complexity, a 2D detector was placed under dif-
ferent measuring conditions (Figure 1). Therefore, 
various thicknesses of semi-anthropomorphic 
FIGURE 1.  2D detector in combination with 
different phantoms: (A) homogeneous phantom; 
(B) CIRS phantom with long axis parallel to 
the beam axis; (C) CIRS phantom in patient 
position; (D) ART phantom-head&neck and (E) 
ART phantom-thorax.
A B C
D E
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phantom CIRS Thorax, with its long axis paral-
lel to the beam central axis (CAX) were placed on 
top of 3 cm water equivalent RW3 plastic plates 
(PTW, Freiburg, Germany). The RW3 plates as-
sure that the dose on the detector would not be af-
fected by transitions between different media and 
potential lack of dose build-up. Different thick-
nesses of CIRS Thorax phantom, e.g. 5, 10 and 15 
cm (Figure 1B) respectively, were used to verify the 
influence of inhomogeneities on measured dose 
distributions. Dose distribution using CIRS Thorax 
phantom with long axis of the phantom perpen-
dicular to CAX (‘clinical position’) was also investi-
gated (Figure 1C). RW3 plates were not used in this 
measuring arrangement since there was enough 
tissue equivalent material in front of the detector. 
Investigation was also performed on three ‘ana-
tomical parts’ of interest (head&neck, thorax and 
pelvic) of anthropomorphic phantom in ‘clinical 
position’ (Figures 1D, E). Here, build-up material 
(RW3 plates) was also used due to large ‘air gaps’ 
between the phantom and the detector, to ensure 
consistency of dose measurement.
Dose calculations were performed using Monaco 
5.11.02 TPS utilizing Dw and Dm reporting modes. 
Different dose distributions were calculated for 
different phantom geometries and configurations 
(Figure 2), having beams directed vertically to the 
measuring plane. Beam geometries ranged from 
simple square (reference) field (15×15 cm2) to clini-
cal IMRT plans of various complexities considering 
fluence maps modulation degrees: 1.25, 1.65, 2.25 
and 3.65 respectively, which is in accordance with 
number of segments (23, 40, 76 and 105 segments, 
respectively). To achieve an appropriate level of 
dose calculation accuracy and consistency, dose 
distributions were calculated with 0.2 cm grid size, 
0.5% statistical uncertainty, and „per control point“ 
calculation mode. Sequencing parameters were as 
follows: minimum segment area: 4 cm2, minimum 
segment width: 1.5 cm, fluence smoothing: medi-
um, minimum MU/segment: 2, maximum number 
of segments per plan: 110. 
Results 
Results of gamma analysis in the homogene-
ous phantom and different combinations of the 
semi-anthropomorphic phantom for various lev-
els of plan complexity as well as different report-
ing modes are presented in Table 1 and Figure 3. 
The results for 3%/3mm and 2%/2mm criteria are 
shown in tables. Due to clarity, only the results 
TABLE 1. Results of gamma analysis for measured and calculated dose distributions in homogeneous and CIRS thorax phantoms for different levels of 
plan complexity and different reporting modes
phantom gamma criteria
15x15 IMRT1 IMRT2 IMRT3 IMRT4
% points passing with gamma<1
Dw Dm Dw Dm Dw Dm Dw Dm Dw Dm
MultiCube
2mm/2% 93,12 95,62 98,68 96,75 99,53 98,62 97,32 96,01 89,59 84,68
3mm/3% 98,74 99,97 99,94 99,33 99,99 99,81 99,65 99,31 98,22 95,93
5N CIRS
2mm/2% 90,13 91,51 96,63 94,94 99,03 98,72 93,68 88,49 78,74 70,37
3mm/3% 97,55 98,71 98,26 98,44 99,94 99,92 98,64 96,19 92,03 84,99
10N CIRS
2mm/2% 88,61 86,14 95,11 92,39 99,14 97,9 93,25 84,54 77,51 70,52
3mm/3% 97,18 96,15 96,07 97,17 99,98 99,64 97,76 92,57 89,48 84,19
15N CIRS
2mm/2% 85,73 86,06 96,35 94,45 98,42 97,42 89,67 84,66 72,16 64,7
3mm/3% 96,44 96,46 99,33 98,17 99,99 99,36 96,97 93,32 86,69 79,06
CIRS
2mm/2% 85,05 81,5 91,72 89,16 97,66 97,09 88,25 82,93 67,29 59,28
3mm/3% 96 95,91 93,98 95,52 99,83 99,27 96,43 92,34 86,72 76,6
A B C
FIGURE 2. Calculated dose distributions for IMRT4 plan on homogeneous (A), CIRS 
phantom with long axis parallel to the beam axis (B) and H&N part of ART phantom (C).
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for 2%/2mm criteria were shown graphically. 
Percentage of points passing with gamma<1 for 
3%/3mm criteria of the IMRT plans degrade de-
pending on the thickness of non-water equivalent 
material up to 12% and up to 19% for dose-to-water 
and dose-to-media reporting mode, respectively. It 
also degrades for the most complex IMRT plan.
Percentage of points passing with gamma<1, 
when using 2%/2mm criteria, degrade depending 
on the level of complexity of plans, up to 30% for 
dose-to-water and up to 37% for dose-to-media 
reporting mode, for CIRS Thorax phantom in the 
patient position.
Results for anthropomorphic phantom are pre-
sented in Table 2 and Figure 4.
Considering more realistic situations in anthro-
pomorphic phantom, gamma passing rates, when 
using 2%/2mm criteria, degrade depending on the 
level of complexity of plans, up to 22% for dose-to-
water and up to 23% for dose-to-media reporting 
mode, both in ART Thorax (worst case scenario).
Percentage differences between gamma passing 
rates using 2%/2mm criteria of dose-to-water and 
dose-to-media reporting mode for different levels 
of plan complexity and different phantom set-ups 
are shown in Figure 5.
Discussion
The motivation for this work was related to a large 
number of very good gamma analysis results gath-
ered while performing patient-specific dosimetry 
for IMRT clinical cases in a standard way using 
homogeneous phantom and 3%/3mm criteria. 
Obtained results were independent of dose report-
ing mode used. Thus, we were interested how the 
above-mentioned patient-specific dosimetry meth-
TABLE 2. Results of gamma analysis for measured and calculated dose distributions in the thorax, pelvic and head and neck parts of Alderson phantom 
for different levels of plan complexity and different reporting modes
 phantom gamma criteria
15x15 IMRT1 IMRT2 IMRT3 IMRT4
% points passing with gamma<1
Dw Dm Dw Dm Dw Dm Dw Dm Dw Dm
Thorax 
Alderson
2mm/2% 86,39 86,18 97,6 96,79 95,02 94,2 86,3 84,59 75,44 73,62
3mm/3% 94,24 96,19 99,26 98,89 97,6 97,07 94,07 93,19 93,57 90,8
Pelvic 
Alderson
2mm/2% 92,05 95,75 99,15 98,16 97,05 94,61 90,85 89,47 78,48 76,33
3mm/3% 99,19 99,82 99,99 99,65 99,5 98,57 97,85 95,72 93,93 92,99
H&N 
Alderson
2mm/2% 91,59 91,82 98,14 97,65 95,96 94,83 95,45 94,1 83,51 79,86
3mm/3% 97,2 98,01 99,65 99,53 99,12 98,14 98,82 98,34 94,73 93,03
FIGURE 3. Gamma analysis with 2%/2mm criteria for dose-to-media (left) and 
dose-to-water (right) reporting modes related to the complexity of the particular 
plan, measured over homogeneous phantom and various set-ups of the semi-
anthropomorphic phantom.
FIGURE 4. Gamma analysis with 2%/2mm criteria for dose-to-media (left) and dose-
to-water (right) reporting modes related to plan complexity, measured over different 
parts of the anthropomorphic phantom.
FIGURE 5. Gamma passing rate differences using 2%/2mm criteria between reporting 
modes related to plan complexity and phantom acquired over homogeneous 
phantom and different set-ups of the semi-anthropomorphic phantom (left) and 
different parts of the anthropomorphic phantom (right).
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odology performs in a more realistic clinical situ-
ation.
From our results, it is evident that the gamma 
passing rate decreases with increasing plan com-
plexity. It also depends on the level of inhomoge-
neity of the analysed region. Data in Table 1 shows 
that for the simplest case gamma passing rate (ref-
erence field and homogeneous phantom) is not as 
superior as expected in comparison to more com-
plex plans and more complex measuring geome-
tries. Further analysis of dose profiles shows that 
differences between calculated and measured val-
ues are insignificant at the exact positions of ioni-
zation chambers in the 2D detector. Nevertheless, 
in the regions of steep dose gradients, the inter-
polation between measuring points deteriorates 
passing rates when 2%/2mm criteria is used. These 
results, suggest that the resolution of the detector 
is one of the limiting factors of the analysis. Latter 
is less pronounced in complex multiple field geom-
etries due to an averaging effect. 
Comparing the data for all set-ups of semi-an-
thropomorphic (Table 1 and Figure 3) and anthro-
pomorphic phantoms (Table 2 and Figure 4) one 
can conclude that passing rates are higher in the 
anthropomorphic phantom. Such observation indi-
cates that the TPS calculates real situation more ac-
curately than the extreme ones when different inho-
mogeneities are separated (Figure 2B). Exceptions 
are the passing rates for the IMRT2 plan, which are 
extremely high in all set-ups of the semi-anthro-
pomorphic phantom since all fields that form this 
plan are small enough to pass through only the ho-
mogeneous part of the phantom.
From Figure 5 one can see that gamma passing 
rate depends on the dose reporting mode used. 
The magnitude of these differences increases as 
plan complexity increases. It also depends on the 
heterogeneity of the region of interest. The influ-
ence of heterogeneity on gamma passing rate dif-
ferences of reporting modes is less pronounced 
in the anthropomorphic phantom (-2.7% to 3.6%) 
than in the semi-anthropomorphic phantom (-2.5% 
to 8.7%). These results raise a question of possible 
limits of dose distribution verification in the as-
sessment of plan delivery quality. Consequently, 
one has to bear in mind the fact that good results 
obtained using standard patient-specific dosimetry 
methodology do not guarantee the accuracy of de-
livered dose distribution in real clinical cases. 
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